| Dr Damon Hou, MD | |
|
6355 Walker Ln Ste 508, Alexandria, VA 22310-3251 | |
| (703) 971-7633 | |
| (703) 971-0997 |
| Full Name | Dr Damon Hou |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 6355 Walker Ln Ste 508, Alexandria, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578534350 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0101059219 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery.
Research conducted by Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service Director and Harvard Medical School Professor Reza Dana, M.D., M. Sc., MPH, and colleagues at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.
Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
› Verified 1 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery.
Research conducted by Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service Director and Harvard Medical School Professor Reza Dana, M.D., M. Sc., MPH, and colleagues at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.
Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
› Verified 1 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20040315000188 |
News Archive
In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery.
Research conducted by Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service Director and Harvard Medical School Professor Reza Dana, M.D., M. Sc., MPH, and colleagues at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.
Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Damon Hou, MD 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Dr Damon Hou, MD 6355 Walker Ln Ste 508, Alexandria, VA 22310-3251 Ph: (703) 971-7633 |
News Archive
In this study, which was published in the journal Frontiers in Immunology on September 30th, researchers used sequencing to characterize the immune system of patients who survive from COVID-19 infection from symptom onset through recovery.
Research conducted by Massachusetts Eye and Ear Infirmary (MEEI) Cornea Service Director and Harvard Medical School Professor Reza Dana, M.D., M. Sc., MPH, and colleagues at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for a range of product improvements to the Company's Visian Implantable Collamer® Lens (ICL™) that more than doubles the current Visian addressable market in Europe.
Scientists at UC Santa Barbara have designed a nanoparticle that has a couple of unique - and important - properties.
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
› Verified 1 days ago
Dr. Kenneth Michael Ahdoot, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave, Suite #902, Alexandria, VA 22304 Phone: 703-370-4300 Fax: 703-370-0044 | |
Ms. Andrea Ellen Williams, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 700 S Washington St Ste 330, Alexandria, VA 22314 Phone: 703-940-3364 Fax: 703-717-4055 | |
Lalitha S Rambhala, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 2 E Glebe Rd, Alexandria, VA 22305 Phone: 703-535-5568 Fax: 703-535-1583 | |
Dr. Tina Tonga Pham, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6355 Walker Ln, 408, Alexandria, VA 22310 Phone: 703-719-5901 Fax: 703-719-9629 | |
Dr. Kristina Kathleen Hibshman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave, Suite 1100, Alexandria, VA 22304 Phone: 703-370-0400 | |
Lauren Michelle Gover, APRN, CNM Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4660 Kenmore Ave Ste 902, Alexandria, VA 22304 Phone: 703-370-4300 Fax: 703-832-0050 | |
Alexis D Light, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 700 S Washington St Ste 330, Alexandria, VA 22314 Phone: 703-940-3364 Fax: 703-717-4055 |